Alavita Pharmaceuticals Inc
1 clinical trials · Sponsor
◉ Watch Alavita Pharmaceuticals Inc
| Record | Firm | Date |
|---|---|---|
| Phase 2 Study of the Safety of Diannexin in Kidney Transplant Recipients (NCT00615966) | Alavita Pharmaceuticals Inc | 2008-02-01 |
Track Alavita Pharmaceuticals Inc automatically
Every clearance here is in the API, with alerts when new ones post.